Neuroscience
Brain Ischemia
95%
Parkinson's Disease
74%
Alzheimer's Disease
42%
Meta-Analysis
35%
Cognitive Disorders
27%
Cerebral Hemorrhage
27%
Obstructive Sleep Apnea
26%
Randomized Controlled Trial
24%
Amyloid
13%
Artificial Neural Network
12%
Cognitive Function
12%
Neurotrauma
12%
Traumatic Brain Injury
12%
Diabetes Mellitus
12%
Mild Cognitive Impairment
11%
Middle Cerebral Artery
10%
In Vivo
9%
Aspirin
9%
Neurodegenerative Disorder
9%
Magnetic Resonance Imaging
9%
Migraine
8%
In Vitro
8%
Sleep Disorder
8%
Platelet
7%
Sleep Quality
7%
Polysomnography
7%
Clopidogrel
7%
Multiple Sclerosis
7%
Neuroprotective Agent
7%
Cerebral Autoregulation
6%
Functional Magnetic Resonance Imaging
6%
Brain Tumor
6%
Nerve Excitability
6%
Rapid Eye Movement Sleep
6%
Antioxidant
6%
Stem Cell
6%
Ischemic Heart Disease
5%
Alteplase
5%
Acetylcholinesterase Inhibitor
5%
Cell Death
5%
Glioblastoma Multiforme
5%
Temozolomide
5%
Excitability
5%
Cell Signaling
5%
Blood Brain Barrier
5%
Peripheral Neuropathy
5%
Stenosis
5%
Tissue Plasminogen Activator
5%
Promoter Region
5%
Magnetic Resonance Imaging
5%
Brain-Derived Neurotrophic Factor
5%
Ischemia
5%
Cyanocobalamin
5%
Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
49%
Parkinson's Disease
37%
Cohort Analysis
36%
Meta-Analysis
27%
Alzheimer's Disease
25%
Cerebral Hemorrhage
22%
Hazard Ratio
18%
Randomized Controlled Trial
18%
Odds Ratio
17%
Blood Clot Lysis
15%
Systematic Review
14%
Diabetes
14%
Obstructive Sleep Apnea
13%
Disease
12%
Biological Marker
12%
Retrospective Cohort Study
12%
Symptom
10%
Magnetic Resonance Imaging
10%
Alteplase
9%
Prevalence
8%
National Institutes of Health Stroke Scale
7%
Clinical Trial
7%
Brain Infarction
7%
Blood Pressure
7%
Cognitive Defect
7%
Drug Therapy
6%
Proportional Hazards Model
6%
Combination Therapy
6%
Malignant Neoplasm
6%
Disseminated Herpes Zoster
6%
Maturity Onset Diabetes of the Young
6%
Amyloid
6%
Acetylcholinesterase Inhibitor
6%
Traumatic Brain Injury
5%
Hyperglycemia
5%
Supplementation
5%
Logistic Regression Analysis
5%
Adverse Event
5%
Motor Performance
5%
Auriculotherapy
5%
Headache
5%
Heart Arrest
5%
Cardiovascular Disease
5%
Degenerative Disease
5%
Excitability
5%
Infarction
5%
Glioblastoma
5%
Modified Rankin Scale
5%
Disability
5%
In Vitro
5%
Diabetic Neuropathy
5%
Atrial Fibrillation
5%
Gut Microbiota
5%
Placebo
5%
Migraine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
52%
Parkinson's Disease
49%
Cohort Study
34%
Alzheimer's Disease
22%
Randomized Controlled Trial
20%
Sleep Disordered Breathing
16%
Brain Hemorrhage
14%
Disease
11%
Symptom
11%
Glioblastoma
10%
Mouse
9%
Clinical Trial
9%
Malignant Neoplasm
9%
Acetylsalicylic Acid
9%
Cognitive Defect
8%
Amyloid
8%
Sleep Disorder
8%
Diabetes Mellitus
7%
Cardiovascular Disease
7%
Adverse Event
7%
Clopidogrel
7%
Neuroprotective Agent
7%
Traumatic Brain Injury
7%
Biological Marker
6%
Alteplase
6%
Tumor Necrosis Factor
6%
Cholinesterase Inhibitor
6%
Combination Therapy
6%
Dopamine Receptor Stimulating Agent
6%
Thrombus
6%
Prevalence
5%
Placebo
5%
Cerebrovascular Accident
5%
Rankin Scale
5%
Non Insulin Dependent Diabetes Mellitus
5%
Motor Dysfunction
5%
Atrial Fibrillation
5%